(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2025-04-02 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 1128410
Date | Daily Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 90.01 | 85.18 | 90.39 | 85.10 | 0.936 times |
01 Tue Apr 2025 | 85.94 | 88.51 | 88.67 | 84.55 | 1.271 times |
31 Mon Mar 2025 | 88.51 | 86.82 | 88.74 | 85.35 | 1.16 times |
28 Fri Mar 2025 | 88.72 | 89.80 | 89.80 | 87.53 | 0.551 times |
24 Mon Mar 2025 | 95.27 | 89.20 | 96.02 | 89.20 | 1.204 times |
21 Fri Mar 2025 | 88.72 | 87.95 | 90.25 | 86.99 | 1.631 times |
20 Thu Mar 2025 | 88.47 | 88.76 | 91.61 | 88.37 | 0.6 times |
19 Wed Mar 2025 | 90.48 | 89.55 | 91.12 | 88.53 | 1.723 times |
18 Tue Mar 2025 | 89.59 | 92.34 | 92.34 | 89.42 | 0.718 times |
17 Mon Mar 2025 | 92.14 | 90.88 | 92.38 | 89.39 | 0.549 times |
My analysis of stock is bullish for shortterm, and stock might move up till 91.3 or till 93.6. Use a stoploss of 89.34 and if this stock hits its stoploss, then it can fall down till 87.4
Share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Target | 84.55 |
Upside Target | 90.14 |
Upside Target | 90.39 |
Upside Target | 91.02 |
Upside Target | 92.38 |
Upside Target | 95.55 |
Upside Target | 96.02 |
Upside Target | 98.41 |
Upside Target | 115.77 |
Upside Target | 118.25 |
Intraday share price targets for Blueprint Medicines (BPMC)
Target Type | Value |
Downside Intraday Target | 86.24 |
Downside Intraday Target | 82.48 |
Upside Intraday Target | 92.08 |
Upside Intraday Target | 94.16 |
Downside Intraday Target | 88.32 |
Weekly technical analysis of Blueprint Medicines (BPMC)
Date | Weekly Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 90.01 | 86.82 | 90.39 | 84.55 | 1.919 times |
28 Fri Mar 2025 | 88.72 | 89.20 | 96.02 | 87.53 | 0.336 times |
21 Fri Mar 2025 | 88.72 | 90.88 | 92.38 | 86.99 | 1.247 times |
14 Fri Mar 2025 | 89.58 | 85.61 | 91.02 | 84.59 | 0.903 times |
07 Fri Mar 2025 | 87.12 | 95.28 | 95.55 | 85.76 | 1.383 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
Date | Monthly Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 90.01 | 88.51 | 90.39 | 84.55 | 0.13 times |
31 Mon Mar 2025 | 88.51 | 95.28 | 96.02 | 84.59 | 0.934 times |
28 Fri Feb 2025 | 96.57 | 109.20 | 115.77 | 90.14 | 1.011 times |
31 Fri Jan 2025 | 112.53 | 88.06 | 118.25 | 86.72 | 1.977 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 89.75 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Blueprint Medicines Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Blueprint Medicines in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 89.75 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.